Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership34,231 shares
Latest Disclosed Value $ 2,076,104
Quadrant Capital Group Llc reports 60.08% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 34,231 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,794,389 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 21,384 shares of Bristol-Myers Squibb Company. This represents a change in shares of 60.08% during the quarter. The current value of the position is $1,623,576 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 34,231 12,847 60.08 2,076 80.05 0.0621
2026-05-11 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 34,231 12,847 49 0.0369
2026-02-12 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,384 -11,088 -34.15 1,153 -21.24 0.0348
2025-11-13 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 32,472 -13,214 -28.92 1,464 -30.75 0.0476
2025-08-13 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 45,686 11,146 32.27 2,115 0.38 0.0761
2025-05-13 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 34,540 21,624 167.42 2,107 188.49 0.0782
2025-02-13 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,916 1,096 9.27 731 19.48 0.0503
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,820 3,830 47.93 612 84.59 0.0425
2024-08-12 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,990 -3,529 -30.64 332 -46.96 0.0246
2024-05-15 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 11,519 -3,007 -20.70 625 -16.24 0.0493
2024-02-08 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 14,526 -2,545 -14.91 745 -24.75 0.0640
2023-11-14 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,071 -731 -4.11 991 -13.01 0.0992
2023-08-10 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,802 -4,026 -18.44 1,138 -24.74 0.1130
2023-05-11 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,828 -1,582 -6.76 1,513 -10.21 0.1575
2023-02-13 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,410 6,071 35.01 1,684 36.58 0.1909
2022-11-10 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,339 404 2.39 1,233 -5.44 0.1631
2022-08-09 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,935 1,054 6.64 1,304 12.41 0.1752
2022-05-06 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,881 2,514 18.81 1,160 39.26 0.1405
2022-02-01 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,367 -370 -2.69 833 2.46 0.0994
2021-11-12 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,737 -264 -1.89 813 -13.14 0.1134
2021-08-09 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 14,001 -1,535 -9.88 936 -4.59 0.1358
2021-05-12 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,536 2,516 19.32 981 21.41 0.1592
2021-02-16 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,020 460 3.66 808 6.74 0.1500
2020-11-13 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,560 705 5.95 757 8.61 0.1650
2020-08-13 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,855 -16,113 -57.61 697 -55.18 0.1543
2020-05-15 2020-03-31 13F Bristol-Myers Squibb Com 110122108 27,968 -299 -1.06 1,555 -12.49 0.2603
2020-03-19 2019-12-31 13F/A-1 Bristol-Myers Squibb Com 110122108 28,267 11,805 71.71 1,777 116.18 0.2143
2020-02-03 2019-12-31 13F Bristol-Myers Squibb Com 110122108 28,267 11,805 1,777 6,004.7148
2019-10-24 2019-09-30 13F Bristol-Myers Squibb COM 110122108 16,462 3,826 30.28 822 47.05 0.1265
2019-07-24 2019-06-30 13F Bristol-Myers Squibb COM 110122108 12,636 -901 -6.66 559 -10.85 0.0885
2019-04-29 2019-03-31 13F Bristol-Myers Squibb COM 110122108 13,537 3,665 37.13 627 26.92 0.1102
2019-01-17 2018-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,872 -572 -5.48 494 -21.59 0.1317
2018-10-29 2018-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,444 411 4.10 630 16.24 0.1800
2018-08-08 2018-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,033 -781 -7.22 542 -18.13 0.1900
2018-05-10 2018-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,814 -325 -2.92 662 -1.19 0.2401
2018-01-31 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 11,139 -61 -0.54 670 -3.74 0.2671
2017-10-13 2017-09-30 13F Bristol Myers Squibb COM 110122108 11,200 149 1.35 696 22.54 0.2871
2017-08-14 2017-06-30 13F Bristol Myers Squibb COM 110122108 11,051 -311 -2.74 568 -6.43 0.2511
2017-04-10 2017-03-31 13F Bristol Myers Squibb COM 110122108 11,362 -41 -0.36 607 -7.19 0.2667
2017-01-11 2016-12-31 13F Bristol Myers Squibb COM 110122108 11,403 3,718 48.38 654 61.08 0.3280
2016-10-25 2016-09-30 13F Bristol Myers Squibb COM 110122108 7,685 -869 -10.16 406 -34.30 0.2649
2016-07-28 2016-06-30 13F Bristol Myers Squibb COM 110122108 8,554 665 8.43 618 24.85 0.4251
2016-04-27 2016-03-31 13F Bristol Myers Squibb COM 110122108 7,889 434 5.82 495 -2.17 0.3208
2016-01-28 2015-12-31 13F Bristol Myers Squibb COM 110122108 7,455 -176 -2.31 506 13.20 0.3502
2015-10-28 2015-09-30 13F Bristol Myers Squibb COM 110122108 7,631 1,034 15.67 447 2.52 0.3084
2015-08-12 2015-06-30 13F Bristol Myers Squibb COM 110122108 6,597 6,597 436 0.2774
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.